Epizyme (EPZM) Misses Q2 EPS by 1c

Epizyme (NASDAQ: EPZM) reported Q2 EPS of ($0.63), $0.01 worse than the analyst estimate of ($0.62). Revenue for the quarter came in at $13 million versus the consensus estimate of $8.72 million.

For earnings history and earnings-related data on Epizyme (EPZM) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c